Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Philip Reigan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Reigan, Philip

Item TypeName
Academic Article Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells.
Academic Article Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells.
Concept MAP Kinase Signaling System
Concept Ribosomal Protein S6 Kinases, 90-kDa
Concept Glycogen Synthase Kinase 3
Concept Protein-Tyrosine Kinases
Concept Protein Kinase Inhibitors
Concept Mitogen-Activated Protein Kinase 1
Concept CDC2 Protein Kinase
Concept AMP-Activated Protein Kinases
Concept Mitogen-Activated Protein Kinase 3
Concept Phosphatidylinositol 3-Kinases
Academic Article Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality.
Academic Article Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma.
Academic Article RSK3: A regulator of pathological cardiac remodeling.
Academic Article Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.
Academic Article A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells.
Academic Article Targeting WEE1 Kinase in Cancer.
Academic Article Selective Targeting of RSK Isoforms in Cancer.
Academic Article Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.
Grant Novel small-molecule inhibitors of Wee1 kinase for medulloblastoma treatment
Academic Article Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.
Concept Glycogen Synthase Kinase 3 beta
Academic Article Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study.
Academic Article Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.
Academic Article Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo.
Academic Article N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors.
Grant Development of AMPK Inhibitors for the treatment of leukemia
Academic Article Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data.

Search Criteria
  • Phosphotransferases

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)